What to Understand Before Talking to Your Doctor About Hormone Therapy for Menopause-Related Mood Changes

Hot flashes and night sweats tend to get the most attention during the menopausal transition, but the changes happening in the brain can feel even more unsettling. In perimenopause, the uneven stretch leading up to menopause, estrogen and progesterone levels rise and fall unpredictably before gradually declining. Because the brain has many estrogen receptors, these shifts can bring on anxiety, depressive dips, poor sleep, and a deep sense of mental fatigue.

For Black women, that experience can be especially difficult. Research, including findings from the Study of Women’s Health Across the Nation (SWAN), shows that Black women often enter perimenopause about two years earlier and report more severe, longer-lasting symptoms than white women. Too often, emotional and cognitive changes are minimized as stress, burnout, or normal aging. Understanding how this transition affects brain chemistry is key to knowing whether hormone replacement therapy can help.

How hormone replacement therapy works

Hormone replacement therapy (HRT), also called menopausal hormone therapy (MHT), is meant to replace declining estrogen and ease symptoms throughout the body. It can be given through patches, gels, sprays, or oral tablets, and it helps steady the body’s temperature control system while restoring hormonal balance.

The right approach depends on your anatomy:

• Combined therapy (Estrogen + Progesterone): If someone with a uterus uses systemic estrogen, it must be paired with progesterone or a synthetic progestogen. This protects the uterine lining from overgrowth and lowers the risk of endometrial hyperplasia and cancer.
• Estrogen-only therapy: People who have had a hysterectomy can usually take estrogen alone without a protective progestogen. This distinction matters especially for Black women, who have higher rates of uterine fibroids and are more likely to have a hysterectomy earlier in life.

HRT is not usually a direct psychiatric treatment, but its effects on mental health can still be significant. By reducing vasomotor symptoms such as night sweats, it can improve deep sleep. When chronic sleep deprivation eases, irritability, low frustration tolerance, and mood instability often improve as well.

What the science says about mood and emotional balance

Recent clinical data suggests hormone therapy may offer real relief for psychological distress. A study published in Menopause followed 260 women, with an average age of 52, who started hormone therapy for clinical reasons over about 4.5 months. By the end of the study, the share of participants with severe psychological symptoms dropped from 62.3% to 24.6% across measures of anxiety, irritability, low mood, and mental exhaustion.

Still, the research was observational and did not include a randomized control group, so it cannot prove hormone therapy alone caused the improvement.

Beyond the data, the personal toll can be profound. Dr. Monica Christmas, Associate Professor of Obstetrics and Gynecology and associate medical director of The Menopause Society, has noted that the menopause transition can be a turbulent time, with many patients feeling as though they no longer recognize their own minds or reactions.

The reality behind menopause 'brain fog'

Midlife brain fog is not a character flaw or early dementia. It often shows up as forgetfulness, difficulty finding common words, and trouble focusing on complex tasks. These changes are linked to falling estrogen levels in the prefrontal cortex and hippocampus, areas that help govern memory and concentration.

Although hormone therapy is often marketed as a quick fix for mental fog, the evidence is still mixed.

A study in Scientific Reports examined a tailored regimen of estriol, a weaker form of estrogen, and progesterone in 20 menopausal women over 12 months. Participants said they experienced better memory, faster processing, and improved problem-solving. But the study was very small, had no placebo control, and the developer disclosed financial and intellectual property connections to the formulation.

A broader review in The Lancet found that current high-quality evidence is not strong enough to recommend HRT specifically for cognitive decline or brain fog. It may still help indirectly by easing sleep problems and hot flashes, but it should not be seen as an automatic cure for mental cloudiness.

Common side effects

Hormone replacement therapy is not a simple on-off switch; it is an adjustment process. Side effects are most common during the first eight to 12 weeks while the body adapts to changing hormone levels. For many women, these early effects fade with time.

According to the Cleveland Clinic, common early side effects include:

• Breast tenderness, swelling, or increased sensitivity
• Mild headaches or migraines
• Nausea, digestive changes, or mild bloating
• Breakthrough spotting or irregular bleeding
• Temporary fluid retention and slight swelling in the hands or feet
• Mood swings or emotional ups and downs

The exact formulation can make a big difference. Synthetic progestogens and micronized progesterone, for example, can cross the blood-brain barrier and may cause grogginess, dizziness, or depressive symptoms in people who are sensitive to hormones.

Instead of treating side effects as a reason to stop immediately, think of them as useful clinical feedback. Often, symptoms can be eased by changing the dose, switching from synthetic progestins to micronized bioidentical progesterone, or adjusting the schedule. Any changes should be made with your prescribing clinician to protect your health and hormonal balance.

Rare or serious side effects

Hormone therapy does carry important risks, and those risks should be weighed against your medical history, age, cardiovascular profile, and when treatment begins.

For generally healthy women under 60 or within 10 years of menopause, the benefits of HRT for moderate to severe symptoms often outweigh the risks. Even so, safety should be assessed based on your individual body and the specific hormones prescribed.

Understanding the FDA labeling updates

The U.S. Food and Drug Administration has approved label changes for several menopausal hormone therapies, removing broad boxed warnings for cardiovascular disease, breast cancer, and probable dementia for qualifying products. This update reflects years of newer clinical evidence showing that the original boxed warnings, based on the 2002 Women’s Health Initiative study, were shaped by research on older women using high-dose synthetic oral regimens.

That said, the update does not mean HRT is risk-free. Product labels still contain detailed safety information that should be reviewed individually.

Delivery route matters: transdermal vs. oral therapy

The way estrogen enters the body can significantly affect risk:

• Oral estrogen: Swallowed tablets pass through the liver first. This can increase clotting factors and inflammatory markers, raising the risk of deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke.
• Transdermal estrogen (patches, gels, sprays): These forms absorb through the skin and enter the bloodstream without going through the liver first. As a result, they carry a much lower baseline risk of blood clots and stroke.

For Black women, who face higher rates of hypertension, metabolic syndrome, and cardiovascular disease, delivery route is an especially important equity issue. If you have personal or family risk factors for heart disease or high blood pressure, asking about transdermal options is an important harm-reduction step.

Some people should not use systemic HRT, including those with certain hormone-sensitive cancers, a history of stroke, heart attack, blood clots, or severe liver disease. Any unexplained vaginal bleeding should also be evaluated before treatment begins.

What to do if you notice symptoms

If you find yourself more impatient, unexpectedly tearful, or more anxious during perimenopause, know that you do not have to wait until the symptoms become unbearable before seeking care.

These emotional shifts are tied to real neurochemical changes, not a personal failing or simply the price of getting older.

1. Ask for a full diagnostic workup

At your appointment, do not settle for being told you are merely stressed. Estrogen changes can overlap with, or look like, other common health problems. Ask your clinician about a thorough lab workup to rule out other causes:

• Complete Blood Count (CBC) and Ferritin: Black women experience uterine fibroids at two to three times the rate of white women and may have heavy bleeding during perimenopause. That can lead to severe iron-deficiency anemia, which can look like brain fog, fatigue, and irritability.
• Full Thyroid Panel (TSH, Free T4): Hypothyroidism can affect mood, energy, and cycle regularity, and it often appears during the same midlife period when perimenopause begins.
• Vitamin D Level: Because melanin reduces the skin’s response to ultraviolet light, deficiency is more common in deeper skin tones and can worsen mood symptoms, joint pain, and fatigue.

2. Seek crisis or specialized mental health support

Not every midlife psychological change is hormonal. If you are dealing with lasting hopelessness, severe panic, deep depression, or trouble functioning, you should get targeted mental health care alongside your hormone evaluation.

If you are having thoughts of self-harm or are in a mental health crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline for free, confidential support any time. For ongoing culturally aware care, directories such as Therapy for Black Girls can help you find professionals who understand the intersection of race, gender, and midlife transitions.

Evidence-based alternatives

Mood changes are not the only menopause symptoms HRT can help. The best option depends on your symptoms, health history, preferences, and whether hormones are safe for you.

Cognitive behavioral therapy (CBT): This form of talk therapy can help you identify and change unhelpful thinking patterns while building coping skills. Menopause-specific CBT may help with low mood, anxiety, and sleep problems.

Antidepressants: Some medicines, including selective serotonin reuptake inhibitors (SSRIs), can help treat depression and anxiety. Some may also reduce hot flushes. They may be appropriate if depression is the main concern or if HRT is not suitable.

Regular physical activity: Walking, swimming, dancing, and other enjoyable movement can improve mood, sleep, and overall health.

Healthy sleep habits: Keep a regular sleep schedule and avoid too much caffeine late in the day. Talk with your health care provider about any sleep trouble or night sweats.

Stress management: Relaxation exercises, mindfulness, and social support may help with emotional changes.

Dr. Justus Rabach, MD, tells Blavity Health that other helpful options can include herbal supplements, omega-3 fatty acids, vitamin D, and calcium, but he advises speaking with a healthcare provider before starting any supplement. He adds that menopause is a natural stage that can still bring challenges, and that understanding the changes and taking proactive steps can help women manage symptoms and maintain a healthy lifestyle.

These options can support medical care, but they are not a replacement for treatment when someone is dealing with severe depression or another condition that needs professional attention.

How and when to step away from HRT

There is no single age or fixed treatment length for stopping HRT. The decision depends on your symptoms, health risks, and treatment goals.

If your mood, sleep, and other menopause symptoms improve, you may wonder whether you still need treatment. Bring that question up at regular checkups. Some people taper slowly, while others stop under medical supervision. Symptoms such as hot flashes, night sweats, and sleep trouble can return after treatment ends.

Your clinician can help you decide whether to restart treatment, adjust the dose, or try another medication if symptoms continue. The goal is to keep a plan that offers more benefit than harm.

Bottom line

HRT can help with menopause-related mood swings, especially when hot flashes and sleep disruption are also present. Early studies suggest it may also help with brain fog, though stronger research is still needed. Before starting or stopping HRT, speak with a knowledgeable healthcare provider about your symptoms, medical history, and options.

Frequently asked questions

Will I age faster if I stop HRT?

No. Stopping HRT does not automatically make you age faster, although some menopause symptoms may come back and affect sleep, comfort, or quality of life.

At what stage is menopause the worst?

Symptoms are often most disruptive during perimenopause, when hormones fluctuate, but the timing and severity differ from person to person.

Citations

Harlow SD, Burnett-Bowie SM, Greendale GA, Avis NE, Reeves AN, Richards TR, Lewis TT. Disparities in Reproductive Aging and Midlife Health between Black and White women: The Study of Women’s Health Across the Nation (SWAN). Womens Midlife Health. 2022;8(1):3. https://pmc.ncbi.nlm.nih.gov/articles/PMC8822825

Fairweather S, Jeffers L, Gossett DR, Friedman E, Twi-Yeboah A, Dunham S. Impact of hormone therapy on mood in a real-world clinical setting: a retrospective observational study. Menopause. Published September 8, 2026. https://menopause.org/wp-content/uploads/press-release/MENO-D-26-00207.pdf

Itoh N, Itoh Y, Patil R, et al. Targeting hormone treatment for the brain in menopause. Scientific Reports. 2026;16(1). doi:10.1038/s41598-026-65603-4

Melville M, He L, Desai R, et al. Menopause hormone therapy and risk of mild cognitive impairment or dementia: a systematic review and meta-analysis. The Lancet Healthy Longevity. 2025;6(12):100803. doi:10.1016/j.lanhl.2025.100803

Cleveland Clinic. Hormone therapy for menopause: Types, benefits & risks. Cleveland Clinic. Published June 28, 2021. https://my.clevelandclinic.org/health/treatments/15245-hormone-therapy-for-menopause-symptoms

FDA. FDA Approves Labeling Changes to Menopausal Hormone Therapy Products. FDA.gov. Published February 12, 2026. https://www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-products